Research reveals how synthesized plankton molecules inhibit cancer proteins
Researchers at the Department of Chemistry, Scripps Research, California, have discovered how to harness the toxic power of plankton to manufacture anti-cancer molecules.
Researchers at the Department of Chemistry, Scripps Research, California, have discovered how to harness the toxic power of plankton to manufacture anti-cancer molecules.
Nothing is easy to predict, especially not the development of organisms. However, predicting neuron cell growth has just become a little bit easier, thanks to CMU researchers.
Sep 11, 2023
0
1
A team at DTU Health Tech, led by Associate Professor Alireza Dolatshahi-Pirouz, has made a leap forward in tissue regeneration by creating a multi-leveled scaffold that encompasses properties of native bone on both the nano, ...
Jun 27, 2023
0
37
A group of researchers led by the Dana-Farber Cancer Institute, Boston, has illustrated the mechanistic pathway for PTEN-deficient breast cancer and successfully tested a method of countering the downstream effects of immune ...
Immunotherapies have improved outcomes of many patients with cancer, including melanoma. But these therapies work for only a subset of patients. Numerous studies are looking at improving responses, including research focusing ...
Jan 23, 2023
0
56
Modeling the growth cycle of a neuron is tricky, as neurons are formed for vastly different functions all over the body. However, every neuron begins its life in about the same way and goes through five distinct stages of ...
Oct 5, 2022
0
46
Researchers focusing on the effects of the MYC oncogene have revealed new information about the factors that regulate the growth of cancer cells. MYC promotes the expression of genes that are important for cellular growth, ...
Sep 27, 2022
0
61
The intestine is very susceptible and is affected by the harsh conditions caused by DNA-altering agents, such as radiation and chemotherapy, during cancer treatment. For example, many patients with tumors in the gastrointestinal ...
Sep 14, 2022
0
7
The multitargeted tyrosine kinase inhibitor (MKI), lenvatinib, is widely used to treat advanced and metastatic thyroid cancer. However, the molecular mechanisms by which thyroid cancer cells become resistant to lenvatinib ...
Sep 13, 2022
0
6
For the 280 million people suffering from depression globally, relief cannot come fast enough. Monoaminergic antidepressants, including selective serotonin reuptake inhibitors (SSRIs) take weeks to months to take effect and ...
May 25, 2022
0
11